Your browser doesn't support javascript.
loading
Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma.
Uchimoto, Taizo; Fukushima, Tatsuo; Komura, Kazumasa; Fukuokaya, Wataru; Adachi, Takahiro; Hashimoto, Takeshi; Yoshizawa, Atsuhiko; Nakamura, Ko; Yano, Yusuke; Nishimura, Kazuki; Nishio, Kyosuke; Nakamori, Keita; Iwatani, Kosuke; Yamamoto, Shutaro; Urabe, Fumihiko; Mori, Keiichiro; Yanagisawa, Takafumi; Tsuduki, Shunsuke; Takahara, Kiyoshi; Inamoto, Teruo; Miki, Jun; Kimura, Takahiro; Ohno, Yoshio; Shiroki, Ryoichi; Egawa, Shin; Azuma, Haruhito.
Afiliación
  • Uchimoto T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Fukushima T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Komura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Fukuokaya W; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Adachi T; Department of Urology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.
  • Hashimoto T; Department of Urology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.
  • Yoshizawa A; Department of Urology, Fujita-Health University School of Medicine, Toyoake City, Aichi, Japan.
  • Nakamura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Yano Y; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Nishimura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Nishio K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Nakamori K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Iwatani K; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Yamamoto S; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Urabe F; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Mori K; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Tsuduki S; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Takahara K; Department of Urology, Fujita-Health University School of Medicine, Toyoake City, Aichi, Japan.
  • Inamoto T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Miki J; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Kimura T; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Ohno Y; Department of Urology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.
  • Shiroki R; Department of Urology, Fujita-Health University School of Medicine, Toyoake City, Aichi, Japan.
  • Egawa S; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
BJU Int ; 131(4): 477-485, 2023 04.
Article en En | MEDLINE | ID: mdl-36098556
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Neoplasias Urológicas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: BJU Int Asunto de la revista: UROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Neoplasias Urológicas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: BJU Int Asunto de la revista: UROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón